Total-body irradiation in advanced non-Hodgkin's lymhoma
- 1 October 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 54 (646), 878-881
- https://doi.org/10.1259/0007-1285-54-646-878
Abstract
Thirty-seven patients with advanced non-Hodgkin''s lymphoma who were treated by total-body irradiation (TBI) are reviewed. Twenty-four patients had received no previous therapy; 13 patients were in relapse. The overall response rate was 73% for nodular lymphomas and 80% for those with diffuse disease. The duration of complete response ranged from 2-41 mo. (median 12 mo.). Subsequent chemotherapy was given successfully except in patients with prolonged thrombocytopenia which appeared to be related to an initially involved bone marrow. Hemibody irradiation (HBI) was the least myelosuppressive form of TBI and is now being used in complete remission following chemotherapy.This publication has 7 references indexed in Scilit:
- Total body irradiation as a secondary therapy in non-Hodgkin's lymphomaClinical Radiology, 1980
- Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphomaCancer, 1979
- Total body irradiation in non-Hodgkin's lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Changes in lymph node size following systemic irradiation for malignant lymphomaClinical Radiology, 1979
- CHEMOTHERAPY (CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE) VERSUS RADIOTHERAPY (TOTAL-BODY IRRADIATION) FOR STAGE-III-IV POORLY DIFFERENTIATED LYMPHOCYTIC LYMPHOMA1978
- Total body irradiation as treatment for lymphosarcomaInternational Journal of Radiation Oncology*Biology*Physics, 1976
- Remission induction and remission duration with primary radiotherapy in advanced lymphosarcomaCancer, 1972